Cited 2 time in
Cited 3 time in
A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling
- A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling
- Nam, Jin Han; Cho, Hyun Ji; Kang, Hye Jin; Lee, Ju Young; Jung, Mi Ra; Chang, Young Chae; Kim, Kee Tae; Hoe, Hyang Sook
- Issue Date
- Journal Of Cellular Biochemistry, 118(12), 4672-4685
- Article Type
- FOCAL ADHESION KINASE; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; HYDROXAMIC ACID; PHASE-II; CANCER; GLIOBLASTOMA; TEMOZOLOMIDE; METASTASIS; PROMOTES
- Histone deacetylase inhibitors (HDACIs) have emerged as potential anticancer agents for the treatment of solid and hematopoietic cancers. Several HDACIs delay cell growth, induce differentiation, or activate apoptosis in multiple types of tumors, including glioblastomas. In the present study, we showed that the mercaptoacetamide-based HDACI W2 inhibits cell migration and invasion in monomorphic malignant human glioma cells. W2 treatment significantly decreased the activity and expression levels of matrix metalloprotease-2 in malignant A172 cells but not in U373MG cells. Key signaling pathways involved in cell migration and invasion, including PI3K-AKT, ERK-JNK-P38, and FAK/STAT3, were examined to identify the mechanism of action of W2. W2 increased the phosphorylation of AKT and altered cell migration and invasion in an AKT-independent manner. W2 inhibited the phosphorylation of FAK/STAT3, and treatment with a FAK/STAT3 inhibitor significantly suppressed cancer cell migration and MMP-2 activity in the presence of W2. In addition, W2 significantly inhibited the nuclear translocation of phospho-STAT3. Taken together, our results suggest that W2 suppresses cancer cell migration and invasion by inhibiting FAK/STAT3 signaling and STAT3 translocation to the nucleus in monomorphic malignant human glioma cells. J. Cell. Biochem. 118: 4672-4685, 2017. (c) 2017 Wiley Periodicals, Inc.
There are no files associated with this item.
- ETC1. Journal Articles
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.